Roche presents new 2-year data for Evrysdi (risdiplam) in infants with Type 1 spinal muscular atrophy (SMA)

    NEXT STORY
    Basilea starts phase 1/2 study FIDES-03 with derazantinib in patients with gastric cancer
    PREV STORY
    Apollomics, Inc. Receives China Investigational New Drug Approval for APL-106 to Initiate a Phase 3 Bridging Study in Acute Myeloid Leukemia
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Y-mAbs to Host Virtual Research & Development Day on Wednesday, December 16

    author_avatar
    NASDAQ Market News

    Livestock Monitoring and Identification Market to Reach USD 3,690.4 Million by 2027; Enlargement of Cattle Industry to Fortify Industry, states Fortune Business Insights™

    author_avatar
    NASDAQ Market News

    Biomarkers Market Size Worth $115.45 Billion By 2027 | CAGR of 13.6%: Reports And Data

    author_avatar
    NASDAQ Market News